{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:33:05Z","timestamp":1790343185480,"version":"4.1.0"},"reference-count":31,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"de cellules souches de l\u2019Universit\u00e9 de Montr\u00e9al"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The purpose of this retrospective study was to study the correlation between donor age (DA) and non-relapse mortality (NRM) and relapse incidence (RI) among patients treated with allogeneic hematopoietic cell transplantation (aHCT) for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in a single Canadian center. Data from 125 consecutive patients transplanted with a matched related or unrelated donor between 2015 and 2020 were analyzed using multivariable models. After a median follow-up of 2.8 years, the cumulative incidences of NRM and relapse were 19% and 35% at 5 years. Despite being independently associated with NRM and relapse-free survival (RFS), DA was not associated with RI. The independent determinants of NRM in addition to DA were patient age and hematopoietic cell transplantation comorbidity index (HCT-CI), independently of donor kinship. The effect of DA on NRM was found to be significantly increased over the age of 50 years. DA was not associated with incidence of acute graft-versus-host disease (aGVHD) but showed an association with the occurrence of chronic GVHD (cGVHD). In conclusion, younger donors should be favored to limit NRM and increase RFS in HLA-matched aHCT. The etiological mechanisms behind the association of DA with higher NRM remain to be elucidated.<\/jats:p>","DOI":"10.3390\/curroncol29080470","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T21:30:34Z","timestamp":1661203834000},"page":"5955-5962","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome"],"prefix":"10.3390","volume":"29","author":[{"given":"Yasmine","family":"Kadri","sequence":"first","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Phan","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacologie & Physiologie, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Bambace","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Bernard","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Cohen","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-S\u00e9bastien","family":"Delisle","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kiss","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lachance","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis-Claude","family":"Roy","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Sauvageau","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Veilleux","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7716-6864","authenticated-orcid":false,"given":"Jean","family":"Roy","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Ahmad","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine, Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3T 1J4, Canada"},{"name":"Institut Universitaire d\u2019H\u00e9matologie-Oncologie & Th\u00e9rapie Cellulaire de Montr\u00e9al, H\u00f4pital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current Use of and Trends in Hematopoietic Cell Transplantation in the United States","volume":"26","author":"Fretham","year":"2020","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, Nonrelapse Mortality, and Relapse-Related Mortality after Allogeneic Hematopoietic Cell Transplantation: Comparing 2003\u20132007 versus 2013\u20132017 Cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: Monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/hematology.2021000257","article-title":"Allogeneic hematopoietic cell transplantation for older patients","volume":"2021","author":"Lin","year":"2021","journal-title":"Hemat. Am. Soc. Hematol. Educ. Program"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: A European Society for Blood and Marrow Transplantation registry retrospective analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"Lancet Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1182\/blood-2012-08-453860","article-title":"Who is the better donor for older hematopoietic transplant recipients: An older-aged sibling or a young, matched unrelated volunteer?","volume":"121","author":"Alousi","year":"2013","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/leu.2012.210","article-title":"Allogeneic stem cell transplantation for older advanced MDS patients: Improved survival with young unrelated donor in comparison with HLA-identical siblings","volume":"27","author":"Zabelina","year":"2013","journal-title":"Leukemia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbmt.2014.09.021","article-title":"Impact of donor age on outcome after allogeneic hematopoietic cell transplantation","volume":"21","author":"Rezvani","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.leukres.2015.05.003","article-title":"Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome","volume":"39","author":"Bastida","year":"2015","journal-title":"Leuk. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S2352-3026(20)30394-X","article-title":"Development and validation of a disease risk stratification system for patients with haematological malignancies: A retrospective cohort study of the European Society for Blood and Marrow Transplantation registry","volume":"8","author":"Shouval","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1986.tb05545.x","article-title":"Female marrow donors increase the risk of acute graft-versus-host disease: Effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum","volume":"63","author":"Atkinson","year":"1986","journal-title":"Br. J. Haematol."},{"key":"ref_15","first-page":"413","article-title":"Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group","volume":"5","author":"Jacobsen","year":"1990","journal-title":"Bone Marrow Transpl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/14653249.2012.681041","article-title":"Influence of related donor age on outcomes after peripheral blood stem cell transplantation","volume":"14","author":"Richa","year":"2012","journal-title":"Cytotherapy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/cncr.30737","article-title":"Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia","volume":"123","author":"Segal","year":"2017","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: A clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2018.02.006","article-title":"Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most","volume":"24","author":"Shaw","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.htct.2017.11.008","article-title":"Donor characteristics and hematopoietic stem cell transplantation outcome: Experience of a single center in Southern Brazil","volume":"40","author":"Paz","year":"2018","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/bloodadvances.2020001620","article-title":"Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy","volume":"4","author":"Mariotti","year":"2020","journal-title":"Blood Adv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","article-title":"Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.bbmt.2019.05.031","article-title":"Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?","volume":"25","author":"Karam","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41409-019-0499-z","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation","volume":"55","author":"Ciurea","year":"2020","journal-title":"Bone Marrow Transpl."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-014-0098-9","article-title":"Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: A phase II randomized study from the Belgian Hematological Society","volume":"8","author":"Baron","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/10428190290016827","article-title":"The role of donor age in naive T-cell recovery following allogeneic hematopoietic stem cell transplantation: The younger the better","volume":"43","author":"Azuma","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2141.2000.02391.x","article-title":"The reconstitution of CD45RBhiCD4+ naive T cells is inversely correlated with donor age in murine allogeneic haematopoietic stem cell transplantation","volume":"111","author":"Hirayama","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bmt.1705195","article-title":"Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia","volume":"37","author":"Carreras","year":"2006","journal-title":"Bone Marrow Transpl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.bmt.1705388","article-title":"Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?","volume":"38","author":"Mehta","year":"2006","journal-title":"Bone Marrow Transpl."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jamaoncol.2021.6846","article-title":"Relapse and Disease-Free Survival in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors","volume":"8","author":"Kim","year":"2022","journal-title":"JAMA Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/8\/470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:13:38Z","timestamp":1760141618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/8\/470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["curroncol29080470"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29080470","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]}}}